309 related articles for article (PubMed ID: 6741906)
21. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.
Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O; Rosén A
Gastroenterology; 1982 Sep; 83(3):550-62. PubMed ID: 6124474
[TBL] [Abstract][Full Text] [Related]
22. An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease.
Korzenik JR; Dieckgraefe BK
Aliment Pharmacol Ther; 2005 Feb; 21(4):391-400. PubMed ID: 15709989
[TBL] [Abstract][Full Text] [Related]
23. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
[TBL] [Abstract][Full Text] [Related]
24. Thalidomide in luminal and fistulizing Crohn's disease resistant to standard therapies.
Plamondon S; Ng SC; Kamm MA
Aliment Pharmacol Ther; 2007 Mar; 25(5):557-67. PubMed ID: 17305756
[TBL] [Abstract][Full Text] [Related]
25. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?
Gaertner WB; Decanini A; Mellgren A; Lowry AC; Goldberg SM; Madoff RD; Spencer MP
Dis Colon Rectum; 2007 Nov; 50(11):1754-60. PubMed ID: 17899271
[TBL] [Abstract][Full Text] [Related]
26. Current treatment modalities in active Crohn's disease.
Biancone L; Pallone F
Ital J Gastroenterol Hepatol; 1999; 31(6):508-14. PubMed ID: 10575571
[TBL] [Abstract][Full Text] [Related]
27. Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease.
Hinterleitner TA; Petritsch W; Aichbichler B; Fickert P; Ranner G; Krejs GJ
Z Gastroenterol; 1997 Aug; 35(8):603-8. PubMed ID: 9297775
[TBL] [Abstract][Full Text] [Related]
28. [Infliximab therapy for Crohn's disease anoperineal lesions].
Ouraghi A; Nieuviarts S; Mougenel JL; Allez M; Barthet M; Carbonnel F; Cosnes J; Gendre JP; Flourié B; Meurisse JJ; Quandalle P; Ernst O; Lemann M; Cortot A; Modigliani R; Colombel JF
Gastroenterol Clin Biol; 2001 Nov; 25(11):949-56. PubMed ID: 11845044
[TBL] [Abstract][Full Text] [Related]
29. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
[TBL] [Abstract][Full Text] [Related]
30. [The course of Crohn disease and side effect profile with long-term treatment using metronidazole].
Gugler R; Jensen JC; Schulte H; Vogel R
Z Gastroenterol; 1989 Nov; 27(11):676-82. PubMed ID: 2515668
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China.
Zheng JJ; Chu XQ; Shi XH; Zhou CL; Seng BW
J Dig Dis; 2008 May; 9(2):84-8. PubMed ID: 18419641
[TBL] [Abstract][Full Text] [Related]
32. Clinical experience with infliximab therapy in 100 patients with Crohn's disease.
Farrell RJ; Shah SA; Lodhavia PJ; Alsahli M; Falchuk KR; Michetti P; Peppercorn MA
Am J Gastroenterol; 2000 Dec; 95(12):3490-7. PubMed ID: 11151882
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics of non-perianal fistulating Crohn's disease in China: a single-center experience of 184 cases.
Wang GF; Ren JA; Liu S; Chen J; Gu GS; Wang XB; Fan CG; Li JS
Chin Med J (Engl); 2012 Jul; 125(14):2405-10. PubMed ID: 22882911
[TBL] [Abstract][Full Text] [Related]
34. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease.
Gao Q; Hogezand RA; Lamers CB; Verspaget HW
Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330
[TBL] [Abstract][Full Text] [Related]
35. Review article: treatment of perianal fistulizing Crohn's disease.
Rutgeerts P
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():106-10. PubMed ID: 15352905
[TBL] [Abstract][Full Text] [Related]
36. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
Hyder SA; Travis SP; Jewell DP; McC Mortensen NJ; George BD
Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753
[TBL] [Abstract][Full Text] [Related]
37. Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease.
Gelbmann CM; Rogler G; Gross V; Gierend M; Bregenzer N; Andus T; Schölmerich J
Am J Gastroenterol; 2002 Jun; 97(6):1438-45. PubMed ID: 12094862
[TBL] [Abstract][Full Text] [Related]
38. Crohn's disease: course, treatment and long term prognosis.
Cooke WT; Mallas E; Prior P; Allan RN
Q J Med; 1980; 49(195):363-84. PubMed ID: 6970371
[TBL] [Abstract][Full Text] [Related]
39. Perianal Crohn's disease in children and adolescents.
Tolia V
Am J Gastroenterol; 1996 May; 91(5):922-6. PubMed ID: 8633582
[TBL] [Abstract][Full Text] [Related]
40. Cheilitis antedating Crohn's disease: case report and literature update of oral lesions.
Talbot T; Jewell L; Schloss E; Yakimets W; Thomson AB
J Clin Gastroenterol; 1984 Aug; 6(4):349-54. PubMed ID: 6481118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
